This is a modal window.
What Medication Should the Patient Have on Discharge and Why? - Dr. Ricardo Pertraco
Summary
Ricardo Petraco focuses on what treatments patients should be on when discharged
- Correct regimen of drugs for ACS patients
- Recognition of the fact that all ACS patients, by definition, are...
Summary
Ricardo Petraco focuses on what treatments patients should be on when discharged
- Correct regimen of drugs for ACS patients
- Recognition of the fact that all ACS patients, by definition, are high-risk
- Targets for cholesterol levels on lipid-lowering therapy
- Additional therapies possible for lipid-lowering to achieve targets (i.e. Ezetimibe)
- Role and evidence of ACE-inhibitors; importance of considering co-existent factors (LV impairment, diabetes, hypertension, renal impairment)
- Role and evidence for beta-blockers and eplerenone
- AF and ACS - triple therapy and other combination therapies
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
Ricardo Petraco
Speaker
Dr Ricardo Petraco is a NIHR Lecturer in interventional Cardiology at Imperial College London,... Dr Ricardo Petraco is a NIHR Lecturer in interventional Cardiology at Imperial College London, performing his clinical work at Hammersmith Hospital. He has been working with coronary physiology at Imperial since 2010 on the development of the novel instantaneous wave-Free Ratio (iFR). Dr Petraco’s work with iFR has led to the proposition of the Hybrid iFR-FFR approach and has established iFR’s close relationship with coronary flow reserve (CFR). His interests in computer programming has led to the development of a software for automated analysis of coronary haemodynamics signals which is been used by many leading centres in the world. He has also pioneered the algorithm for iFR calculation without the need for an ECG signal, an approach which is now implemented in clinical consoles. He has secured several research grants and published extensively in the field of coronary physiology. His current research interests are on the development of methodologies to assess stenosis severity in situations of haemodynamic instability and on the understanding of how medical therapies modulate coronary resistance and flow. Clinically, his interests also include the use of intravascular imaging modalities to optimise PCI and has been engaged in IVUS training for cathlab staff and cardiology trainees.
